Los Angeles — Sept. 25, 2018 — LifeNet Health today announced the launch of PliaFX^® Prime, an advanced biomaterial with unsurpassed versatility. Currently available in limited release, PliaFX Prime consists of 100 percent precision-engineered cortical fibers that provide moldable handling, without the use of additives found in putties.

“PliaFX Prime leverages innovations that have made LifeNet Health the global standard in allograft surgical solutions,” said Rony Thomas, LifeNet Health President and CEO. “It marks a new era in biomaterials.”

Thanks to proprietary processing technology, the interlocking fibers in PliaFX Prime feature microhooks that naturally link together, allowing the graft to become moldable upon rehydration and resist migration during implantation. It is the latest addition to the PliaFX family of moldable fiber-based grafts, which launched in 2017 with the release of the PliaFX Strip preformed construct.

“PliaFX Prime breaks new ground in biomaterials by achieving outstanding handling and ease of use in a carrier-free graft,” said Heather Pierce, General Manager of Spine and General Orthopedics at LifeNet Health. “We worked closely with leading clinicians throughout the development process to ensure PliaFX Prime delivers an exceptional operative experience.”

Attendees at the North American Spine Society (NASS) Annual Meeting in Los Angeles can feel the PliaFX Prime difference at LifeNet Health’s exhibit (booth 2311) Sept. 26-28. A dedicated handling area will enable a hands-on experience with the graft, as well as an up-close look at the unique fibers that comprise the graft.

PliaFX Prime is indicated for spine, trauma, foot and ankle, and craniomaxillofacial applications requiring a bone void filler to support bone formation in defects caused by injury or surgical procedures.